abstract |
Indolinone derivative compounds useful as EWS-FLI1 transcription factor inhibitors are provided. Also provided are pharmaceutical compositions of the indolinone derivatives, methods of synthesizing the indolinone derivatives, methods of treatment using the indolinone derivatives, and assays for the identification of EWS-FLI1 oncoprotein inhibitors. |